Abstract
Over the past decades, the healthcare system in oncology has undergone significant changes associated with the introduction of information and digital technologies, new diagnostic and treatment algorithms based on visually controlled and fundamentally new technologies of surgical, radiation and drug treatment. These changes also affected socially significant oncological diseases, including cervical cancer (cervical cancer). However, it has not yet been completely possible to adequately solve the problem of diagnosing breast cancer within the 0-I stage of the disease and maintain the priorities of "monotherapy" (organ-preserving options for surgical or radiation treatment). At the same time, the treatment of locally advanced cervical cancer (International Federation of Gynecology and Obstetrics (FIGO) 2009/2018 – stages IB2-IVA/IB3-IVA) has not undergone major changes for almost 80 years and, at the same time, only radiation therapy was considered the standard of treatment for this spread of the tumor process. It should be emphasized that currently the development and implementation of increasingly expensive multicomponent treatment programs for such patients is ongoing, aimed, among other things, at achieving fairly satisfactory results, both in patients' survival and in their quality of life.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: "Radiation and Risk" Bulletin of the National Radiation and Epidemiological Registry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
